Board member since 2000
Education: MSc, Stockholm School of Economics.
Main employment: Investor in life sciences, new materials, and software.
Other assignments: Chairman of the board of Acuvi AB and Corline Biomedical AB (publ.).
Previous assignments: Chairman of the board of Senzime AB (publ).
Adam Dahlberg is independent of the company and its executive management but not in relation to other major shareholders of the company.
Shareholding in Senzime: Adam Dahlberg owns 3,601,344 shares of Senzime. In addition, Ebba Fischer owns 2,048,409 shares, the Crafoord Foundation 1,731,766 shares, Margareta Nilsson 2,231,142 shares, Anna Manhusen 1,358,230 shares, AB Pethle 244,663 shares and Carl Rosenblad 271,546 shares in the company, all of which are related to Adam Dahlberg.